Table 3.
Group | n | TNF-α (µg/mL) | IL-1β (µg/mL) | IL-6 (µg/mL) | IL-10 (µg/mL) |
---|---|---|---|---|---|
N | 12 | 16.68 ± 0.20 bc | 18.70 ± 0.77 c | 17.64 ± 0.33 d | 20.40 ± 0.33 d |
S | 12 | 20.65 ± 0.43 a | 20.78 ± 0.78 b | 23.68 ± 1.26 a | 22.38 ± 0.48 c |
L | 12 | 15.72 ± 1.25 d | 18.55 ± 0.78 c | 21.20 ± 0.91 c | 22.48 ± 0.18 c |
M | 12 | 17.53 ± 0.36 b | 21.46 ± 0.34 ab | 22.71 ± 1.80 ab | 23.54 ± 0.25 a |
H | 12 | 14.37 ± 0.93 e | 16.38 ± 1.76 d | 21.93 ± 0.37 bc | 23.42 ± 0.32 ab |
P | 12 | 16.57 ± 0.45 cd | 22.09 ± 0.13 a | 18.71 ± 0.56 d | 23.05 ± 0.31 b |
Values not sharing letters in the same vertical column differ significantly from one another by one-way ANOVA and Duncan’s Multiple Range Test (p < 0.05) among six groups. N: Normal group, S: Sepsis group (i.p. LPS), L: Sepsis group with low-dose WBG, M: Sepsis group with moderate-dose WBG, H: Sepsis group with high-dose WBG, P: Positive control group (i.p. PDTC).